Financial reports
10-K
2023 FY
Annual report
29 Feb 24
10-Q
2023 Q3
Quarterly report
8 Nov 23
10-Q
2023 Q2
Quarterly report
8 Aug 23
10-Q
2023 Q1
Quarterly report
9 May 23
ARS
2022 FY
Annual report to shareholders
1 May 23
10-K
2022 FY
Annual report
1 Mar 23
10-Q
2022 Q3
Quarterly report
8 Nov 22
10-Q
2022 Q2
Quarterly report
8 Aug 22
10-Q
2022 Q1
Quarterly report
6 May 22
10-K
2021 FY
Annual report
1 Mar 22
Current reports
8-K
Fourth quarter revenue growth of 26% YoY driven by strong and profitable Medicare enrollment growth
27 Feb 24
8-K
Results of Operations and Financial Condition
26 Jan 24
8-K
Departure of Directors or Certain Officers
20 Nov 23
8-K
Entered AEP on strong financial and operational foundation
8 Nov 23
8-K
Strong second quarter results; 2023 guidance increased
8 Aug 23
8-K
Submission of Matters to a Vote of Security Holders
21 Jun 23
8-K
Strong first quarter performance reflects positive impact of ongoing transformation plan
9 May 23
8-K
Regulation FD Disclosure
1 May 23
8-K
Results of Operations and Financial Condition
28 Feb 23
8-K
Departure of Directors or Certain Officers
8 Feb 23
Registration and prospectus
S-8
Registration of securities for employees
8 Nov 22
S-3
Shelf registration
24 Aug 22
S-8
Registration of securities for employees
8 Aug 22
S-8
Registration of securities for employees
22 Mar 22
POS AM
Prospectus update (post-effective amendment)
1 Mar 22
POSASR
Automatic shelf registration (post-effective amendment)
28 Feb 22
S-8
Registration of securities for employees
8 Oct 21
S-3ASR
Automatic shelf registration
30 Jun 21
D
$225M in equity, sold $225M, 1 investor
14 May 21
S-8
Registration of securities for employees
19 Aug 20
Proxies
DEFA14A
Additional proxy soliciting materials
1 May 23
DEF 14A
Definitive proxy
1 May 23
DEFA14A
Additional proxy soliciting materials
11 May 22
DEFA14A
Additional proxy soliciting materials
2 May 22
DEF 14A
Definitive proxy
2 May 22
DEFR14A
Revised proxy
16 Jun 21
DEF 14A
Definitive proxy
17 May 21
DEFA14A
Additional proxy soliciting materials
6 May 21
DEFA14A
Additional proxy soliciting materials
30 Apr 21
DEFA14A
Additional proxy soliciting materials
23 Mar 21
Other
EFFECT
Notice of effectiveness
8 Sep 22
CORRESP
Correspondence with SEC
2 Sep 22
UPLOAD
Letter from SEC
2 Sep 22
EFFECT
Notice of effectiveness
3 May 22
UPLOAD
Letter from SEC
16 Jun 20
CORRESP
Correspondence with SEC
29 May 20
CORRESP
Correspondence with SEC
20 May 20
UPLOAD
Letter from SEC
6 May 20
UPLOAD
Letter from SEC
24 Oct 19
CORRESP
Correspondence with SEC
17 Oct 19
Ownership
4
FRANCIS S SOISTMAN JR
12 Apr 24
4
Michelle Marie Barbeau
12 Apr 24
4
John Joseph Dolan
12 Apr 24
4
Gavin G. Galimi
12 Apr 24
4
John Joseph Dolan
9 Apr 24
4
FRANCIS S SOISTMAN JR
9 Apr 24
4
Gavin G. Galimi
9 Apr 24
4
John J Stelben
9 Apr 24
4
FRANCIS S SOISTMAN JR
26 Mar 24
4
John Joseph Dolan
15 Mar 24